Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART
Combined antiretroviral therapy (cART) extends the lifespan and the quality of life for HIV-infected persons but does not completely eliminate chronic immune activation and inflammation. The low level of chronic immune activation persisting during cART-treated HIV infection is associated with the de...
Saved in:
Main Authors: | Joshua J. Anzinger, Tiffany R. Butterfield, Thomas A. Angelovich, Suzanne M. Crowe, Clovis S. Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2014/569819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
by: Caron A. Jacobson, et al.
Published: (2012-01-01) -
Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection
by: Aura Temereanca, et al.
Published: (2025-01-01) -
Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
by: Anna Rull, et al.
Published: (2010-01-01) -
Platelet–Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease
by: Yuan Zhang, et al.
Published: (2025-02-01) -
Carte blanche
by: Jean Kempf
Published: (2021-10-01)